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Colony-stimulating factors (CSFs)' are glycoproteins that regulate the hemo-
poietic progenitor cells to proliferate and differentiate. Murine CSFs were well
characterized, and four of them, multi-, granulocyte/macrophage (GM)-, gran-
ulocyte (G)-, and macrophage (M)-CSF, were purified to homogeneity (1). Multi-
CSF acts on variouscommittedhemopoietic progenitor cells as wellaspluripotent
stem cells, while G-CSF and M-CSF preferentially stimulate the formation of
granulocytes and macrophages, respectively. GM-CSF supports the proliferation
ofgranulocyte/macrophage populations and, at very high concentrations, it was
alsoreported (2) to stimulate megakaryocyte (MK), eosinophil (Eo), and erythroid
colony formation as well. Recent analyses of complementary DNA (cDNA)
encoding murine multi- (3, 4) and GM-CSF (5-7), revealed that these factors
belong to distinct molecular species and bear no structural similarity.
We previously reported that when a murine T cell line, 2E10.4.13, was
stimulated with PMA, the cells produced at least five hemopoietic activities,
including erythroid burst-promoting activity (BPA), erythropoietin (Ep), GM-
colony stimulating activity (CSA), MK-GSA, Eo-CSA, and IL-3, in addition to
the lymphocyte growth factor, IL-2, even in serum-free medium (8). In ion-
exchange HPLC, although all of the hemopoietic activities were more or less
associated with IL-3 activity as assayed using an IL-3-dependent cell line, the
distinct peak of each activity existed also in the region where no IL-3 activity
was detected. Therefore, we concluded that CSF activities mediated by the
distinct molecules from IL-3 were produced by the T cell line, which prompted
us to study further the hemopoietic factors generated from this cell line by using
a molecular cloning technique.
We here report the functional characterization ofhemopoiesis of recombinant
'Abbreviations used in this paper:
￿
BPA, burst-promoting activity; CSA, colony-stimulating activity;
CSF, colony-stimulating factors; Eo, eosinophil; Ep, erythropoietin; G, granulocyte; LGL, large
granular lymphocyte; M, macrophage; MK, megakaryocyte; PWM-SCM, PWM-stimulated spleen
cell-conditioned medium.
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GM-CSF (rGM-CSF) derived from IH5.5 cells, which were cloned from the same
parental cell line as 2E10.4.13.
Materials and Methods
Mice.
￿
Inbred female ICR, BALB/c, and BDF, mice, aged 10-15 wk, and pregnant
ICR mice were purchased from the Shizuoka Experimental Animal Center (Shizuoka,
Japan).
Inducer T Cell Line, IH5.5.
￿
A continuous cell line, IH5.5, was obtained in the process
of cloning the IL-2-dependent large granular lymphocyte (LGL) line, PEC-1, from
BALB/c mouse peritoneal exudate cells injected with syngeneic RL&I leukemia cells (9).
The majority of PEC-1 line cells showed LGL morphology, and the cloning by limiting
dilution resulted mostly in typical LGL clones with NK activity. However, a small number
of colonies with distinct features were also obtained from LGL colonies, clone IH5.5
being one of them. Clone IH5.5 lacked cytoplasmic granules and serological analysis
indicated the phenotype of Thy-1+,Lyt-1+,Lyt-2-,T200+. They were also distinct from
RLd1 cells used for the in vivo stimulation, in that RWI cells were Thy-1+,Lyt-1-,Lyt-2-
and did not produce lymphokines. The ,B gene of the T cell receptor was productively
rearranged in the IH5.5 clone. The rearrangement pattern, however, was distinct from
parental PEC-1, as well as the LGL clones derived thereof, making it very unlikely that
they were directly derived from LGL. Such T cell lines were obtained only in the process
of cloning, and their growth was independent of IL-2. A minor fraction of inducer type
T cells seems to have coexisted in an original PEC-1 line and their outgrowth in mass
cultures seems to have been inhibited by the majority of LGL in the continuous line.
Preparation ofCrude Conditioned Medium.
￿
IH5.5 cells were maintained in RPMI 1640
tissue culture medium (Gibco Laboratories, Grand Island, NY) supplemented with 10%
FCS (Flow Laboratories, Inc., McLean, VA), as described previously (9). Conditioned
medium was prepared as follows: The cellswere incubated with 50 ngml of PMA(Sigma
Chemical Co., St. Louis, MO) and 1% PHA M (Difco Laboratories, Inc., Detroit, MI) in
the absence of FCS. After 48 h of incubation, the supernatant was harvested, filter-
sterilized, and used as the crude conditioned medium, designated crude-CM.
IL-2 and IL-3 Assays.
￿
IL-2-dependent (CTLL-2) and IL-3-dependent cell lines (FDC-
P2) were used for the assays of IL-2 and IL-3 activities. In brief, 104 cells were suspended
in 0.1 ml RPMI 1640 medium supplemented with 10% FCS then plated in a microtiter
well to which we added 0.1 ml of the sample to be tested. After incubation for 18 h, 0.5
uCi of [sH]thymidine (sp act, 15 Ci/mmol) in 20 gl RPMI 1640 medium was added to
each well, then incubation was continued for a further 8 h. The radioactivity incorporated
into the cells was counted with a scintillation counter (Aloka Co., Ltd., Tokyo, Japan).
Chromatography.
￿
A 40-fold concentrate of crude-CM was applied to a 2 X 60 cm
column of Sephadex G-100 (Pharmacia Fine Chemicals, Uppsala, Sweden) that had been
equilibrated with 0.05 M Tris-HCI buffer, pH 7.4, containing 150 mM NaCI, 10 mM
CaCl2- 2H20, and 0.05% PEG. The column was flushed with the same buffer at 4°C, and
2-ml fractions were collected and assayed. In this column, BPA, GM-CSA, MK-CSA, Eo-
CSA, IL-2, and IL-3 were eluted at almost the same region immediately after the major
protein peak. These active fractions were pooled, concentrated 15-fold, and subjected to
HPLC. Ion-exchange HPLC was carried out as follows: The concentrate was dialyzed
against 0.02 M Tris-HCI, pH 7.4, containing 0.02% Tween 20 (Wako Pure Chemical
Industries, Tokyo, Japan) and was applied to a TSK-Gel IEX-500 QAE-2SW (5 'Um, 4.6
X 250 mm; Toyo Soda, Tokyo, Japan) that had been equilibrated with the same buffer.
Elution was first performed at room temperature for 10 min with the starting buffer,
then with the starting buffer and a linear gradient of 0 M-0.5 M NaCl for 75 min, and
finally with the starting buffer containing 0.5 M NaCl for 10 min. The flow rate was 0.5
ml/min throughout these procedures. The effluent was collected as 0.3-ml fractions per
tube and was used for the assays after a threefold dilution with DME.
Cell Preparations.
￿
Bone marrow cells were prepared from femurs of ICR andBALB/c
mice, and phagocytic cells were eliminated by treatment with carbonyl iron (GAF Corp.,1104 A GRANULOCYTE/MACROPHAGE COLONY-STIMULATING FACTOR
New York) as previously described (10). The nonphagocytic cells were used for granulo-
cyte/macrophage, megakaryocyte, eosinophil and erythroid colony assays. Fetal liver cells
were collected from fetuses of ICR mice at 12 days of gestation and were dissociated
mechanically in DME (Gibco Laboratories) by successive passages through 22- and 27-
gauge needles. The nonadherent, nonphagocytic cells were used for the erythroid colony
assays.
10- to 15-wk-old female BDF I mice were administered 5-fluorouracil (5-FU) (Adria
Laboratories, Inc., Columbus, Ohio) through the tail vein at a dosage of 150 mg/kg body
weight. Spleen cells were harvested 4 d later, and we prepared single-cell suspensions
from three to five mice.
Construction of Plasmid and Preparation of Recombinant CSF.
￿
The mouse T cell line
IH5 .5 (clone Al) was stimulated with 1% PHA and 50 ng/ml of PMA. The cells were
harvested 6 h and 9 h after stimulation . Total cellular RNA was extracted from the cells
by using the guanidinium thiocyanate method (I1), and poly(A)+ RNA was selected by
oligo(dT) cellulose column chromatography. Aliquots of the two induced mRNA samples
were then pooled for the construction of a cDNA library. The cDNA library was
constructed by using the pcDV I vector-primer and pLI linker fragment according to the
procedures of Okayama and Berg (12). About 6 pg of poly(A)+ RNA yielded -6 X 105
independent transformants.
Two synthetic oligodeoxynucleotides, 5'-TGG AAG CAT GTA GAG GCC-3' and 5'-
CTG GCC TGG GCT TCC TCA-3', were synthesized according to the available sequence
of GM-CSF from murine lung (5). Two probes were used to screen ^-3 X 104 colonies of
the cDNA library transferred onto 541 filters from Whatman Inc. (Clifton, NJ). Hybrid-
ization conditions used overnight at 50'C were: 6X SSC (1 X SSC = 0.15 M NaCl and
0 .015 M sodium citrate, pH 7 .2), 1 X Denhardt's (0.02% Ficoll, 0.02% polyvinyl-pyrrolli-
done, and 0.02% BSA), 0 .1 % SDS, and 50 Ag/ml of denatured salmon sperm DNA. The
filters were washed at 50°C with two changes of 6X SSC for 30 min. One clone out of 3
X 104 clones gave a positive signal with two probes and was designated pHS mGM-CSF .
The plasmid DNA pHS mGM-CSF, which promoted the expression of mGM-CSF in
mammalian cells, was transfected into COS-1 cells by the DNA-calcium phosphate
coprecipitation technique (13). After transfection, the medium was replaced with serum-
free DME. After 72 h, we collected the medium and characterized the translation product,
termed rGM-CSF, by using various colony assay systems.
ColonyAssays.
￿
GM and Eo, and MK colonies were assayed by soft-agar culture methods
described elsewhere (14), using ICR and BALB/c mice bone marrow cells, respectively.
The agar gel was fixed and stained (10). Cell aggregates containing ?50 naphthol AS-D
chloroacetate-/a-naphthol butyrate esterase-staining positive cells (14), >_4 acetylcholin-
esterase-staining positive cells (15), and ?50 Bieblich scarlet-staining positive cells (16)
were scored as the respective GM, MK, and Eo colonies. The erythroid colony assay was
carried out by the methylcellulose culture method (8), using both ICR mouse bone
marrow (105 cells/ml) and fetal liver cells (105 cells/ml). At the end of 72 h of incubation,
1 U/ml of purified human urinary Ep with a specific activity of 81,600 U/mg protein (the
kind gift of Dr. M. Ueda, Snow Brand Milk Co. Ltd., Tochigi, Japan) was overlaid on the
methylcellulose culture. After 8 d, cell aggregates containing >50 erythroid cells, or ?3
compact subcolonies of erythroid cells, were counted as erythroid bursts. Then, the
colonies were picked up from the methylcellulose culture, spun in a Shandon cytocentri-
fuge, and then the lineage expression of colonies was investigated.
Colony assays using spleen cells from 5-FU-treated mice were carried out as follows:
Methylcellulose culture was performed by using a modification of the technique described
previously (17). Spleen cells (1 .2 X 106 cells/ml) from 5-FU-treated mice were incubated
in 1 ml of culture medium containing a-medium (Gibco Laboratories), 1 .2% methylcel-
lulose (Fisher Scientific Co., Pittsburgh, PA), 30% FCS, 1 % deionized BSA (Sigma
Chemical Co.), 0.1 mM 2-ME (Sigma Chemical Co.) and samples. On day 12 ofincubation,
the number of colonies was scored, lifted from the methylcellulose cultures using a 3-kl
Eppendorf pipet under microscopic visualization, and then individually suspended in 0.1KAJIGAYA ET AL.
￿
1105
TABLE I
Hemopoietic Activities and Lymphokines Detected in the Medium Conditioned by IH5.5 Cells
Stimulated with PMA and PHA
Medium conditioned
with
Number ofcolonies* Radioactivityincorpo-
rated (cpm)$
GM Eo MK E¢ IL-2 IL-3
Cells
￿
0
￿
0
￿
0
￿
1 ± 1
￿
5,919
￿
600
Cells + PMA-PHA
￿
48 ± 5
￿
0
￿
35 ± 3
￿
26 ± 3
￿
59,734
￿
10,150
Crude serum-free medium conditioned by IH5.5 cells stimulated with or without the combination
of PMA and PHA.
* GM, Eo, or MK per 5 X 10" bone marrow cells in soft agar cultures; E per 105 bone marrow cells
in methylcellulosecultures. Data are shown as themean t SD of triplicate cultures.
Radioactivity incorporated into CTLL-2 or FDC-P2 cells. Normal bone marrow cells were incu-
bated with the samples.
§ On day 7 of soft agar culture, colonies were fixed and stained, then counted. Erythroid colony
assay was performed by the methylcellulose culture method, in which purified Ep was added after
72 h and the colonies were scored on day 8 of culture. Data are shown as the mean ± SD of
triplicate cultures.
ml of a-medium . The cell suspensions were spun in a cytocentrifuge from Shandon
Southern Instruments Inc. (Sewickley, PA) and stained with May-Grunwald-Giemsa.
Spleen cells from 5-FU-treated mice were cultured to obtain the blastcell colonies (17).
Briefly, spleen cells were incubated in the methylcellulose culture medium as described
above, by the addition of PWM-stimulated spleen cell-conditioned medium (PWM-SCM)
(18). On day 7 of incubation, blast cell colonies containing 20-100 cells were lifted from
the methylcellulose medium and pooled. The cells were washed twice with a-medium to
remove the effect of PWM-SCM and were replated, at a concentration of 300 cells or a
single cell per ml, into a 35-mm culture dish containing 1 ml of methylcellulose medium
supplemented with each sample. Transfer of a single cell was performed using a micro-
manipulator (Narishige Scientific Instrument Laboratory, Tokyo, Japan), as described
previously (17). After 7 d of incubation, all cell aggregates were picked up from methyl-
cellulose culture, spun in a cytocentrifuge (Shandon Southern Instruments Inc.), and
stained with May-Grunwald-Giemsa. The size of small colonies (<500 cells) was estimated
in situ, and that of larger colonies by using a counting chamber.
Results
Production ofMultiple Hemopoietic Factorsfrom a Cloned T Cell Line, IH5.5.
￿
As
shown in Table I, BPA, GM-CSA, and MK-CSA, as well as IL-2 and IL-3
activities, were detected in the crude-CM of IH5.5 stimulated with PMA and
PHA, while no Eo-GSA was detected. IH5.5 cells ceased proliferation when we
added either PMA or PHA, or significantly increased in cell size almost imme-
diately when both were added. Since IL-3 was shown to have multihemopoietic
activity (19), fractionation of each hemopoietic activity in crude-CM was per-
formed with reference to IL-3 activity. When the conditioned medium was
fractionated by ion-exchange HPLC with a linear gradient of NaCl, hemopoietic
factors were eluted in three distinct regions of 0.02-0.1 M, 0.18-0.25 M, and
0.33-0.38 M NaCl (Fig. 1). IL-3 activity (0 .02-0.1 M) was associated with BPA,
as well as with a minor peak of GM- and MK-CSA, whereas the major peaks of
GM- and MK-CSA were detected in the region that is distinct from IL-3 (0.33-
0.38 M). These results indicated that the T cell line produced GM- and MK-CSF
distinct from IL-3 .1106 A GRANULOCYTE/MACROPHAGE COLONY-STIMULATING FACTOR
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FIGURE 1 . Ion-exchange HPLC. (A) Granulocyte colonies (O), macrophage colonies (9),
granulocyte/macrophage mixed colonies (X), and 0.05 M linear gradient of NaCl in 0.02 M
Tris-HCl,pH 7.4,containing 0.02% Tween20 (-);(B) IL-3 activity (0)and erythroidcolonies
(N); (C) megakaryocyte colonies (A), and the absorbance at 280 nm (- --).
Selective GM Colony-stimulating Activity of rGM-CSF.
￿
Gene cloning of murine
GM-CSF (mGM-CSF) has already been reported (5-7) using lung cells from
mouse injected with bacterial endotoxin and two T cell lines, EL-4 stimulated
with PMA and LB-3 stimulated with Con A. Using a portion ofthe sequence of
the GM-CSF, a candidate gene, pHS mGM-CSF was cloned from a cDNA library
of the T cell clone, IH5.5, as described in Materials and Methods. Serum-free
conditionedmedium was prepared from COS-1 cells transfected withpHS mGM-
CSF and was used to characterize the activity of the translation products, rGM-
CSF. Table II shows the resultsofcolony assays usingbone marrow cells prepared
from normal mice. When the crude-CM of IH5.5 stimulated with PMA and
PHA was added to soft-agar or a methylcellulose culture system containing bone
marrow cells, GM, MK, and erythroid colonies formed. rGM-CSF, on the other
hand, induced only the formation of granulocyte/macrophage colonies. In the
case of the methylcellulose culture using fetal liver cells, we saw very few
erythroid bursts in addition to nonerythroid colonies in the presence of rGM-
CSF and highly purified Ep. By contrast, the crude-CM stimulated the formation
of many erythroid bursts, while we saw no erythroid bursts in the presence of
purified Ep alone (Table III). To further distinguish the cells in the nonerythroid
colonies from bone marrow and fetal liver cells, these colonies were picked up
from the methylcellulose medium and stained with May-Grunwald-Giemsa. All
of the nonerythroid colonies lifted from the cultures containing rGM-CSF
consisted of granulocytes and/or macrophages, and no other cell types were
found. On the other hand, when crude-CM was used, nonerythroid colonies
contained a variety of hemopoietic cells, including neutrophils, macrophages,TABLE II
Morphologic Types of Colonies Derivedfrom Normal Bone Marrow Cells
KAJIGAYA ET AL.
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Normal bone marrow cells were incubated with rGM-CSF, mock-COS-SUP, or crude-CM. On day
7 of soft agar culture, colonies were fixedand stained, and then scored. Erythroidcolony assay was
performed by the methylcellulose culture method, in which purified Ep wasadded after 72 h. On
day 8 of culture, colonies were scored, picked up, and then stained with May-Grunwald-Giemsa.
Data are shownas the mean ± SD of triplicate cultures.
* rGM-CSF, supernatant of COS-1 cells transfected with plasmid-carrying GM-CSF-cDNA; mock-
COS-SUP, supernatant of mock-transfected COS-1 cells; crude-CM;crudeconditioned medium of
IH5.5 cells.
t GM, Eo, or MK per 5 X 10' bone marrow cells in soft agar cultures; E per 105 bone marrow cells
in methylcellulosecultures.
TABLE III
Morphologic Types of Colonies Derivedfrom Normal Fetal Liver Cells
Normal fetallivercellswere incubatedwith rGM-CSF, mock-COS-SUP, crude-
CM, or purified Ep, with (+) or without (-) the addition of purified human
urinary Ep (1 U/ml) as an overlayer after 72 h. On day 8 ofculture, colonies
were counted, picked up, and then stained with May-Griinwald-Giemsa. Data
are shown as the mean ± SD of triplicate cultures.
* See the footnote for Table II.
$ Ep, 1U/ml purified human urinary Ep.
$ Nonerythroid or erythroid colonies per 5 X 10' cells in methylcellulose
cultures.
Stimulus* Concentra-
tion GM
Number
Eo
of colonies$
MK E
(%)
rGM-CSF 10 23 ± 5 0 0 0
20 46 ± 6 0 0 0
Mock-COS-SUP 10 0 0 0 0
20 0 0 0 0
Crude-CM 10 33 ± 4 0 23 ± 3 19 ± 5
20 56 t9 0 61±6 68 t8
Stimulus* Concentration E
Number
Nonery-
throid
of colonies§
Erythroid
(%)
rGM-CSF 10 - 36 t 9 0
+ 41±6 2t2
20 - 63±5 0
+ 58±10 3±1
Mock-COS-SUP 10 - 0 0
+ 0 0
20 - 0 0
+ 0 0
Crude-CM 10 - 73 ± 8 0
+ 64±12 18±4
20 - 95 ± 15 0
+ 87±17 39 f6
Ep 1 U/ml - 0 0
+ 0 01108 A GRANULOCYTE/MACROPHAGE COLONY-STIMULATING FACTOR
TABLE IV
Morphologic Types of Colonies Derivedfrom Spleen Cells of5-FU-treated Mice
Spleen cells of 5-FU-treated mice were cultured with rGM-CSF, mock-COS-SUP, crude-CM, or
PWM-SCM. On day 7 of culture, after counting the number of colonies, each colony was picked
up andstained with May-Griindwald-Giemsa, and themorphologic type ofthecells wasdetermined.
* See the footnote of Table II . PWM-SCM; pokeweed mitogen-stimulated spleen cell conditioned
medium.
$ Number of colonies per 1,2 X 10' spleen cells derived from 5-FU-treated mice. GMM, granulo-
cyte/macrophage-megakaryocyte colonies. Data areshownas themean ±SD of triplicate cultures.
4 N, neutrophils.
megakaryocytes, and erythroblasts. In neither assay described above could the
formation of colonies be observed by the addition of mock-COS-SUP. These
results showed that rGM-CSF was functionally distinct from the IL-3 . Indeed,
rGM-CSF did not support the growth of the IL-3-dependent cell line, FDC-P2.
rGM-CSF Does Not Act on Pluripotent Stem Cells.
￿
To determine the target of
rGM-CSF, a more critical colony assay was performed in which 5-FU-treated
mouse spleen cells were used as target cells. On day 12 of methylcellulose culture,
the colonies were picked up and stained with May-Grunwald-Giemsa (Table IV).
When PWM-SCM that also contained IL-3 was added to the culture, we found
a variety of hemopoietic cells, including neutrophils, macrophages, megakaryo-
cytes, erythroblasts, and mast cells, in the developed colonies. The crude-CM of
stimulated IH5.5 cells showed similar biological activities. In contrast, rGM-CSF
exhibited no stimulatory activities for the formation of colonies from 5-FU-
treated mouse spleen cells, indicating that rGM-CSF could not act on 5-FU-
resistant pluripotent stem cells.
Development ofGM-Coloniesfrom Blast Cells by rGM-CSF.
￿
Further investigation
was carried out by blast colony assay techniques. Spleen cells from 5-FU-treated
mice were incubated in methylcellulose culture medium supplemented with
PWM-SCM. After 7 d, blast colonies were picked up and pooled. The pooled
cells were replated at a concentration of 300 cells/ml into a new methylcellulose
culture medium containing either PWM-SCM, rGM-CSF, or mock-COS-SUP,
followed by the incubation for 7 d (Table V). May-Grunwald-Giemsa staining
revealed that the colonies formed by rGM-CSF were composed preferentially of
neutrophils and/or macrophages, whereas various types of cells other than
neutrophils and macrophages were also seen in PWM-SCM-stimulated colonies.
Mock-COS-SUP showed no stimulatory activities. Single cells in blast colonies
were transferred to the dishes with rGM-CSF by using a micromanipulator
(Table VI). On day 7 of culture, all the cell aggregates formed were lifted from
the methylcellulose medium, centrifuged, and stained (Fig. 2) . From 103 cultures
of single cells, 67 proliferating clones developed. Among them, 43 colonies
containing 7-8,500 cells were composed exclusively of macrophages, 10 colonies
containing 500-8,500 cells consisted of neutrophils, and there were 14 colonies
Stimulus*
Number
GM
of colonies$
MK GMM N M Eo
Lineages§
MK E Mast
rGM-CSF 1 ± 1 0 0 + + - - - -
Mock-COS-SUP 0 0 0 - - - - - -
Crude-CM 10±2 2±2 2±1 + + - + - +
PWM-SCM 18±2 6± 1 6±2 + + + + - +KAJIGAYA ET AL.
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TABLE V
Morphologic Types ofColonies Formed by Replating Blast Cells Derivedfrom 5-FU-treated
Mouse Spleen Cells
Stimulus
Number of colonies
￿
Lineages
GM MK GMM Mast N M Eo MK E Mast
rGM-CSF
￿
146 ± 16
￿
0
￿
0
￿
0
￿
+
￿
+
￿
-
￿
-
￿
-
￿
-
Mock-COS-SUP
￿
0 0 0 0 - - - - - -
PWM-SCM
￿
37±7 3±1 4±I I±1 + + + + - +
See footnotesfor Tables 1, 11, and IV. Spleen cells (1 .2 X 106 cells/ml) from 5-FU-treated mice were
cultured with PWM-SCM. On day 7 of incubation, blastcell colonies were pooled and replated at a
rate of 300 cells/ml into the methylcellulose medium containing rGM-CSF, mock-COS-SUP, or
PWM-SCM. After7dof culture, colonies were counted, lifted, andthen stained with May-Griinwald-
Giemsa. Data are shown as the mean ± SD of triplicate cultures.
TABLE VI
Morphologic Types ofColonies Formed by Replating Single Blast Cells Derived
from 5-FU-treated Mouse Spleen Cells
See footnote to Table IV. Spleen cells (1 .2 X 106 cells/ml) from 5-FU-treated mice
were cultured with PWM-SCM. On day 8 of incubation, blast cell colonies were
pooled andsingle blastcellswere replated into themethylcellulosemedium containing
rGM-CSF. After 7 d of culture, colonies were scored and picked up. Then the cells
in each colony were counted, and then stained with May-Griinwald-Giemsa for
differential counting.
* Rangeof the number of cellscontained in a single colony. See footnote to Table IV.
The percentage of neutrophils contained in each neutrophil/macrophage (NM) col-
ony.
containing 33-15,000 cells ofneutrophilsand macrophages together (Table VI).
In this culture, we saw no other hemopoietic lineage cells. The percentage of
neutrophils in the neutrophil/macrophage mixed colonies varied considerably
from colony to colony, ranging from 4.8 to 72.0%. The numbers of cells
contained in the colonies were also distributed in a wide range. No relation was
found between the size ofcolony and the percentage ofneutrophils in individual
colonies.
Discussion
We performed the present study to define the in vitro hemopoietic activity of
GM-CSF produced by an inducer T cell line. A gene for GM-CSF was cloned
from a cDNA library ofa T cell clone, IH5.5, usinga part ofthe DNA sequence
of a GM-CSF gene obtained from murine lung cells (5), and rGM-CSF was
obtained by the expression of COS-1 cells.
Number of cells
Number
N
of
M
colonies
NM
Neutrophils in each NM colony*
M)
7-100 0 9 1 4.8
100-999 3 19 0
1,000-4,999 5 12 6 16.0, 32 .8, 33.6, 59.2, 64.8, 72.0
5,000-9,999 3 2 3 4.0, 6.4, 21 .6
10,000-15,000 0 0 4 5.6, 13.6, 16.0, 21 .2
Total 10 43 141110 A GRANULOCYTE/MACROPHAGE COLONY-STIMULATING FACTOR
FIGURE 2 .
￿
In situ appearance of (A) a macrophage colony, (B) a neutrophil/macrophage
colony, and (C) a neutrophil colony derived from single cells in the culture containing rGM-
CSF . a, b, and c are portions of the May-Griinwald-Giemsa-stained preparations obtained
from colonies A, B, and C, respectively .
rGM-CSF was first tested in standard colony assay systems of soft agar and
methylcellulose by using normal bone marrow cells . The results indicated that
only neutrophil/macrophage colonies were formed by rGM-CSF . In a subsequent
experiment, fetal liver cells were used as target cells . The rGM-CSF alone failed
to stimulate the formation of erythroid bursts. Combined stimulation with rGM-
CSF and purified Ep led to the formation of only a few erythroid bursts,
compared with the combination of crude-CM and Ep . It thus seems that rGM-
CSF does not have significant BPA activity . Preliminary experiments using a
larger amount of purified rGM-CSF derived from Escherichia coli revealed the
same results mentioned above (data not shown) .KAJIGAYA ET AL.
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Treatment of mice with a high dose of 5-FU has been reported (20, 21) to
result in a significant enrichment of the more primitive hemopoietic stem cells.
We used this system to study the action ofrGM-CSF on pluripotent hemopoietic
progenitors. When spleen cells derived from 5-FU-treated mice were incubated
with crude-CM or PWM-SCM, GM and MK, as well as mixed colonies, were
formed. In contrast, rGM-CSF was completely inactive on such spleen cells. We
have already reported (22, 23) that IL-3 supported the colony growth from 5-
FU-treated mouse spleen cells. The rGM-CSF, however, can stimulate colony
formation by blast cells that had been grown in thepresence of PWM-SCM from
5-FU-treated mouse spleen cells. These colonies consisted solely of neutrophils
and/or macrophages, whereas control cultures supplemented with PWM-SCM
induced various types of colonies (neutrophil, macrophage, megakaryocyte,
eosinophil, and mast cell). We did not see eosinophils in either assay. We checked
the dose-response curve for the colony formation stimulated by rGM-CSF rang-
ingfrom 2.5 to 10%. The colony size increased with increase in the concentration
of rGM-CSF, although the proportion of neutrophil colonies to macrophage
colonies was constant. It could either be due to selective GM-CSF receptor
distribution or to intrinsic programming for differentiation in the target cells. A
binding assay of radiolabeled rGM-CSF is in progress. rGM-CSF supported the
growth of GM colonies from single cells isolated from blast cell colonies by
micromanipulation. It thus indicated that rGM-CSF acted directly on committed
precursors without the accessory cells and supported the differentiation into
mature neutrophils and macrophages. The basis for the lineage restriction of
rGM-CSF is not known yet.
The single lineage colonies were not always smaller than bilineage colonies.
For example, one of the neutrophil/macrophage colonies contained only 33
cells, and a pure neutrophil colony contained 8,500 cells. This shows that the
number of cell divisions occurring after commitment is quite variable. This
concept is not in agreement with the model that exhibits a relatively constant
number of cell doubling during the maturation process. Lineage restriction and
loss ofproliferative capacity ofindividual progenitors may bedepicted as separate
stochastic processes. We also showed that the ratios of neutrophils and macro-
phages in the mixed colonies derived from single cells in the presence of rGM-
CSF varied greatly, ranging from 4.8 to 72.0%. This means that GM-CSF is
permissive for the proliferation ofneutrophils and macrophages, but it does not
determine the differentiation pathway. How the differentiation programs pro-
gress in the presence of hemopoietic growth factors remains to be discovered.
In conclusion, rGM-CSF obtained from a Tcell line was confirmed to prefer-
entially and directly act on committed GM progenitor cells without effecting
either pluripotent stem cells or progenitors of hemopoietic cells other than
neutrophils and macrophages.
Summary
The cDNA for the murine granulocyte/macrophage colony-stimulating factor
(GM-CSF) was cloned from a cDNA library obtained from a murine T cell line,
IH5.5, by using two synthetic probes that encoded two parts of the GM-CSF
from murine lung. The cDNA inserted into the plasmid vector pcDV1 was
transfected into monkey COS-1 cells and the conditioned medium was used to111 2 A GRANULOCYTE/MACROPHAGE COLONY-STIMULATING FACTOR
investigate the hemopoietic activities of the resultant product, recombinant GM-
CSF (rGM-CSF), by means of various colony assays. rGM-CSF stimulated only
neutrophil/macrophage colonies in the cultures of murine normal bone marrow
and fetal liver cells. No other colony stimulating activities (CSA) were seen in
the preparation including burst-promoting activity, eosinophil-CSA, megakary-
ocyte-CSA and mast cell-CSA. rGM-CSF could not support colony formation of
5-fluorouracil-treated mouse spleen cells, in which only the primitive population
of stem cells survived. However, after culture of these cells with PWM-spleen
cell-conditioned medium (PWM-SCM), the colonies consisting of blast cells were
formed. These blast cells could now be induced to form neutrophil/macrophage
colonies in the presence of rGM-CSF. Pure neutrophil colonies, pure macrophage
colonies, as well as mixed neutrophil/macrophage colonies, were formed from
these single blast cells in the presence of rGM-CSF by micromanipulation . rGM-
CSF did not act on pluripotent hemopoietic stem cells, but did act directly and
selectively on neutrophil/macrophage progenitors. Moreover, striking hetero-
geneities were noted in the size ofthe colonies and the proportionof components.
GM-CSF is, therefore, considered to play a noninstructive role in the differentia-
tion of the GM pathway.
Receivedfor publication 17June 1986.
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